✦ LIBER ✦

P2-160: Csf Aβ and tau levels in Alzheimer’s disease and mild cognitive impairment

✍ Scribed by Martin Ingelsson; Elin Blom; Hiroaki Fukumoto; Henrik Zetterberg; Nina Gårevik; Kaj Blennow; Bradley T. Hyman; Lars Lannfelt; Lars-Olof Wahlund; Michael C. Irizarry

Book ID: 118463065
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 71 KB
Volume: 2
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2006.05.998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CSF cortisol in Alzheimer's disease and

CSF cortisol in Alzheimer's disease and mild cognitive impairment

✍ Julius Popp; Karsten Schaper; Heike Kölsch; Gabriela Cvetanovska; Fatima Rommel; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 118 KB

IC-P2-142: Association of CSF total Tau

IC-P2-142: Association of CSF total Tau and phospho-tau (181) with cerebral atrophy in mild cognitive impairment and Alzheimer's disease

✍ Philipp A. Thomann; Elmar Kaiser; Johannes Pantel; Marco Essig; Johannes Schröde 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 88 KB

P3-073: CSF Aβ42, Tau and phosphorylated

P3-073: CSF Aβ42, Tau and phosphorylated Tau are biomarkers for Alzheimer's disease neuropathology and predict development of Alzheimer's disease in patients with mild cognitive impairment

✍ Herukka, Sanna-Kaisa; Tapiola, Tero; Hallikainen, Merja; Tervo, Susanna; Helisal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

CSF Aβ42 and tau in Parkinson's disease

CSF Aβ42 and tau in Parkinson's disease with cognitive impairment

✍ Thomas J. Montine; Min Shi; Joseph F. Quinn; Elaine R. Peskind; Suzanne Craft; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract We tested the hypothesis that the CSF biomarker signature associated with Alzheimer's disease (AD) is present in a subset of individuals with Parkinson's disease and Dementia (PD‐D) or with PD and Cognitive Impairment, Not Dementia (PD‐CIND). We quantified CSF Aβ~42~, total tau (T‐tau),

P3-076: CSF Tau levels and APOEϵ4 carrie

P3-076: CSF Tau levels and APOEϵ4 carriership predict the progression of mild cognitive impairment to Alzheimer's disease

✍ Ingelsson, Martin; Blom, Elin; Zetterberg, Henrik; Fukumoto, Hiroaki; Hyman, Bra 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Value of CSF β-amyloid1–42 and tau as pr

Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment

✍ Hampel, H; Teipel, S J; Fuchsberger, T; Andreasen, N; Wiltfang, J; Otto, M; Shen 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB